phenobarbital has been researched along with Jaundice, Cholestatic in 2 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, T | 1 |
| Kuye, S | 1 |
| Sherman, A | 1 |
| FOUTS, JR | 1 |
2 other studies available for phenobarbital and Jaundice, Cholestatic
| Article | Year |
|---|---|
Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit.
Topics: Bilirubin; Cholagogues and Choleretics; Female; Gestational Age; Humans; Infant, Newborn; Infant, Pr | 2018 |
FACTORS AFFECTING HEPATIC MICROSOMAL ENZYME SYSTEMS INVOLVED IN DRUG METABOLISM.
Topics: Alloxan; Aminopyrine; Carcinoma, Hepatocellular; Chlordan; Chlorpromazine; Codeine; Hexobarbital; Ja | 1963 |